| Tyyppi : |
Lehti |
|
| Tutkimus Joukkueet : |
Toronto - The Hospital for Sick Children, Department of Pharmacy, |
| Tekijät : |
Lingertat-Walsh K, Law S, Walker S.E. |
| Otsikko : |
Stability of Extemporaneously Compounded Domperidone 5 mg/mL Suspension in Oral Mix in Plastinc and Glass Bottles and Plastic Syringes. |
| Numero : |
Can J Hosp Pharm ;71,3:165-172 2018 |
|
| Todisteiden määrä : |
|
| Fyysinen vakaus : |
|
| Kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| Commentairesvaleur : |
|
Luettelo yhdisteistä
 Domperidone
|
 |
 |
 |
 |
250 mg
® = Ranbaxy Pharmaceutical |
|
25°C |
 |
| 75 |
 |
|
|
|
|
|
250 mg
® = Ranbaxy Pharmaceutical |
|
4°C |
 |
| 91 |
|
|
|
|
 |
|
250 mg
® = Ranbaxy Pharmaceutical |
|
25°C |
|
| 75 |
|
|
|
|
|
|
250 mg
® = Ranbaxy Pharmaceutical |
|
4°C |
|
| 91 |
|
|
|
|
 |
|
250 mg
® = Ranbaxy Pharmaceutical |
|
25°C |
|
| 75 |
|
|
|
|
|
|
250 mg
® = Ranbaxy Pharmaceutical |
|
4°C |
|
| 91 |
|
|
|
|
 |
|
7,5 mg
® = Ranbaxy Pharmaceutical |
|
25°C |
|
| 75 |
|
|
|
|
|
